Nov 11, 2021 6:00am EST RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting
Nov 09, 2021 6:00am EST Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Sep 07, 2021 6:00am EDT RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid Tumors
Dec 02, 2020 7:00am EST RenovoRx Continues with Strong Momentum and Reaches Milestone of 100th Patient Enrolled in its Phase III TIGeR-PaC Clinical Trial
Sep 15, 2020 6:00am EDT RenovoRx Named 2020 Drug Delivery Technology Winner in the Fierce Innovation Awards for Life Sciences
Jun 02, 2020 7:00am EDT RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
